Home
THURSDAY, JULY 6, 2017
SESSION 1 • NASH IN OTHER SETTINGS
Chairs: Arun Sanyal (US) and Patrick Marcellin (FR)
SESSION 2 • GETTING TO THE HEART OF THE MATTER
Chairs: Bruno Vergès (FR) and Ariel Cohen (FR)
SESSION 3 • CLINICAL HOT TOPICS
Chairs: Mohammad Siddiqui (US) and Philippe Mathurin (FR)
SESSION 4 • THE ROLE OF THE GUT IN NASH
Chairs: Lawrence Serfaty (FR) and Gyongyi Szabo (US)
  • Plasticity of the mucosal barrier: Insights into regulation of the Intestinal Epithelial Barrier and Steatohepatitis
    Asma Nusrat (US)
  • Endocrine signaling from the gut and its implications for NASH
    Bart Staels (FR)
  • Impact of macronutrient constituents of diet on NASH phenotype and outcomes
    Jean-Francois Dufour (CH)
  • Diet-microbiome interactions and NASH
    Puneet Puri (US)
SESSION 5 • INFLAMMATION
Chairs: Alexandre Louvet (FR) and Stanislas Pol (FR)
SESSION 6 • TECHNOLOGIC INNOVATIONS IN NASH
Chairs: Rohit Loomba (US) and Jean-Pierre Bronowicki (FR)
FRIDAY, JULY 7, 2017
SESSION 7 • INNOVATIONS IN FIBROSIS ASSESSMENT
Chairs: Pierre Bedossa (FR) and Scott Friedman (US)
SESSION 8 • SHORTENING TIMELINES AND IMPROVING EFFICIENCY IN DRUG DEVELOPMENT
Chairs: Mark DeLegge (US) and Dominique Larrey (FR)
SESSION 9 • REGULATORY LANDSCAPE
Chair: Lawrence Serfaty (FR)
SESSION 10 • STATE OF THE ART LECTURE
Chair: Arun Sanyal (US)
  • Closing Remarks by Arun Sanyal (US)